Avadel Pharmaceuticals Plc Sponsored ADR AVDL 深 滬
等待開盤 10-28 09:30:00 美东时间
18.56
0.000
0.00%
華盛通- 最 高18.60
- 今 開18.55
- 成交量 179.84万股
- 最 低 18.54
- 昨 收 18.56
- 總市值 18.08亿
- 52周最高 18.65
- 市盈率 靜 --
- 換手率 1.85%
- 52周最低 6.38
- 委 比 96.72%
- 總股本 9740.34万
- 歷史最高 19.09
- 量 比 0.13
- 振 幅 0.32%
- 歷史最低 1.03
- 每 手 1
- 風險率 2.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多华兴资本医疗与生命科技行业周报【Vol.389】
来源：华兴资本 “华兴资本医疗与生命科技行业周报”定期发布，专注从资本角度解读一周数据，并提供最新行业观察。 医疗与生命科技是华兴资本多年来关注并深耕的领域，目...
10-27 09:30
美股大行评级 | 上调目标价！特斯拉、赛默飞世尔、拉姆研究、波士顿科学、安诺电子、金沙集团等获众多机构评级
今日重点评级关注：摩根士丹利：维持Viking Therapeutics"超配"评级，目标价从98美元升至102美元；摩根大通：维持IDEAYA Biosciences"超配"评级，目标价从74美元升至79美元
10-24 09:51
Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target
Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Outperform to Market Perform and announces $18.5 price target.
10-24 05:52
美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
10-23 10:06
Beyond The Numbers: 5 Analysts Discuss Avadel Pharmaceuticals Stock
In the preceding three months, 5 analysts have released ratings for Avadel Phar...
10-23 02:00
Needham Downgrades Avadel Pharmaceuticals to Hold
Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold.
10-22 22:37
Alkermes to Acquire Avadel Pharmaceuticals for $2.1 Billion
Alkermes ( ($ALKS) ) has provided an update. On October 22, 2025, Alkermes anno...
10-22 21:29
Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH J...
10-22 19:00
Avadel Pharmaceuticals Settles Lawsuits with Jazz Pharmaceuticals
Avadel Pharmaceuticals ( ($AVDL) ) has shared an announcement. On October 21, 2...
10-22 18:58
Avadel Pharma Announces Global Settlement Of All Litigation With Jazz Pharma
Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all litigation with Jazz Pharmaceuticals Inc.
10-22 18:34
